ArticleScience translational medicine2015

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma.

Laura A Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.